Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5166

Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitor

$
0
0
Eli Lilly keeps putting its GLP-1 windfall to use. On Monday, the anti-obesity drugmaker announced its latest deal to expand its pipeline of future drugs, saying it would spend as much as

Viewing all articles
Browse latest Browse all 5166

Latest Images

Trending Articles



Latest Images